Adaptimmune Therapeutics News

H.C. Wainwright Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 14 05:35 ET

Adaptimmune Therapeutics Analyst Ratings

BenzingaAug 13 14:02 ET

Leerink Partners Maintains Adaptimmune Therapeutics(ADAP.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsAug 13 10:32 ET

Scotiabank Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $3.15

Moomoo NewsAug 13 09:33 ET

A Quick Look at Today's Ratings for Adaptimmune Therapeutics(ADAP.US), With a Forecast Between $1 to $4

Moomoo NewsAug 13 09:00 ET

Scotiabank Sticks to Its Buy Rating for Adaptimmune Therapeutics (ADAP)

TipRanksAug 13 07:27 ET

Buy Rating Affirmed for Adaptimmune Therapeutics Amidst Promising Product Launch and Strong Pipeline

TipRanksAug 13 06:24 ET

Adaptimmune Therapeutics: A Cautious Hold Amid Gradual Launch and Long-Term Growth Strategy

TipRanksAug 13 05:08 ET

Adaptimmune Therapeutics (ADAP) Gets a Sell From Barclays

TipRanksAug 13 04:51 ET

Mizuho Securities Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating

Moomoo NewsAug 7 02:32 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)

TipRanksAug 7 02:06 ET

Scotiabank Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $3.15

Moomoo NewsAug 6 09:33 ET

Scotiabank Remains a Buy on Adaptimmune Therapeutics (ADAP)

TipRanksAug 6 09:06 ET

Adaptimmune Therapeutics Analyst Ratings

BenzingaAug 5 05:55 ET

Barclays Maintains Adaptimmune Therapeutics(ADAP.US) With Sell Rating, Maintains Target Price $1

Moomoo NewsAug 5 04:33 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Lantheus (LNTH) and Vertex Pharmaceuticals (VRTX)

TipRanksAug 5 03:56 ET

H.C. Wainwright Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 2 11:32 ET

JonesTrading Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Cuts Target Price to $2

Moomoo NewsAug 2 11:32 ET

Adaptimmune Therapeutics Analyst Ratings

BenzingaJul 30 07:19 ET

H.C. Wainwright Initiates Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Announces Target Price $4

Moomoo NewsJul 30 06:33 ET